Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism
Open accessAbstract
G protein α s (GNAS) mediates receptor-stimulated cAMP signalling, which integrates diverse environmental cues with intracellular responses. GNAS is mutationally activated in multiple tumour types, although its oncogenic mechanisms remain elusive. We explored this question in pancreatic tumourigenesis where concurrent GNAS and KRAS mutations characterize pancreatic ductal adenocarcinomas (PDAs) arising from intraductal papillary mucinous neoplasms (IPMNs). By developing genetically engineered mouse models, we show that Gnas R201C cooperates with Kras G12D to promote initiation of IPMN, which progress to invasive PDA following Tp53 loss. Mutant Gnas remains critical for tumour maintenance in vivo. This is driven by protein-kinase-A-mediated suppression of salt-inducible kinases (Sik1-3), associated with induction of lipid remodelling and fatty acid oxidation. Comparison of Kras-mutant pancreatic cancer cells with and without Gnas mutations reveals striking differences in the functions of this network. Thus, we uncover Gnas-driven oncogenic mechanisms, identify Siks as potent tumour suppressors, and demonstrate unanticipated metabolic heterogeneity among Kras-mutant pancreatic neoplasms.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
More recent IPMN mouse models that genocopy recurrent driver alterations (Kras, Gnas, Rnf43) demonstrate stepwise progression comparable to patient-derived IPMNs.
“More recent IPMN models have been generated that genocopy recurrent driver alterations observed in cognate human lesions (i.e. Kras, Gnas, Rnf43) (Fig 1)34–36, and these models demonstrate the comparable stepwise progression observed in patient derived IPMNs.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239 · see citing works
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621 · see citing works
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380 · see citing works
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · see citing works
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask‐Andersen, M., Schiöth, H. B., & Gloriam, D. E. I. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,609 · see citing works
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123 · see citing works
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043 · see citing works
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019 · see citing works
Self-citationThe LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943 · see citing works
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628 · see citing works
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259 · see citing works
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Witkiewicz, A. K., McMillan, E. A., Balaji, U., Baek, G., Lin, W.-C., Mansour, J., Mollaee, M., Wagner, K.-U., Koduru, P., Yopp, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7744 · Cited by 1,115 · see citing works
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Zechner, R., Zimmermann, R., Eichmann, T. O., Kohlwein, S., Haemmerle, G., Lass, A., & Madeo, F. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.018 · Cited by 1,105 · see citing works
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals
Altarejos, J. Y., & Montminy, M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3072 · Cited by 1,035 · see citing works
Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1158703 · Cited by 1,033 · see citing works
Self-citationThe role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors
Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R. J., & Wright, C. V. E. (2002) · Nature Genetics · doi:10.1038/ng959 · Cited by 1,007 · see citing works
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002 · see citing works
Self-citationInhibition of the EGF-Activated MAP Kinase Signaling Pathway by Adenosine 3′,5′-Monophosphate
Wu, J., Dent, P., Jelı́nek, T., Wolfman, A., Weber, M. J., & Sturgill, T. W. (1993) · Science · doi:10.1126/science.7694366 · Cited by 919 · see citing works
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 884 · see citing works
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Wu, J., Matthaei, H., Maitra, A., Molin, M. D., Wood, L., Eshleman, J., Goggins, M., Canto, M., Schulick, R., Edil, B., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002543 · Cited by 786 · see citing works
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Collins, M. A., Bednar, F., Zhang, Y., Brisset, J.-C., Galbán, S., Galbán, C. J., Rakshit, S., Flannagan, K. S., Adsay, N. V., & Pasca di Magliano, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59227 · Cited by 770 · see citing works
Peroxisomes: A Nexus for Lipid Metabolism and Cellular Signaling
Lodhi, I. J., & Semenkovich, C. F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.002 · Cited by 605 · see citing works
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
Dickins, R., Hemann, M., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G., & Lowe, S. (2005) · Nature Genetics · doi:10.1038/ng1651 · Cited by 561 · see citing works
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer
O’Hayre, M., Vázquez‐Prado, J., Kufareva, I., Stawiski, E. W., Handel, T. M., Seshagiri, S., & Gutkind, J. S. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3521 · Cited by 559 · see citing works
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Caro, P., Kishan, A. U., Norberg, E., Stanley, I. A., Chapuy, B., Ficarro, S. B., Polak, K. Z., Tondera, D., Gounarides, J., Yin, H. X., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.014 · Cited by 522 · see citing works
The Cyclic AMP PathwayPreprint
Sassone‐Corsi, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011148 · Cited by 519 · see citing works
Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
Honeyman, J. N., Simon, E. P., Robine, N., Chiaroni-Clarke, R. C., Darcy, D. G., Lim, I. I. P., Gleason, C. E., Murphy, J. M., Rosenberg, B. R., Teegan, L., et al. (2014) · Science · doi:10.1126/science.1249484 · Cited by 491 · see citing works
Beard, C., Hochedlinger, K., Plath, K., Wutz, A., & Jaenisch, R. (2006) · genesis · doi:10.1002/gene.20180 · Cited by 482 · see citing works
Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells
Wang, Y. Y., Attané, C., Milhas, D., Dirat, B., Dauvillier, S., Guérard, A., Gilhodes, J., Lazar, I., Alet, N., Laurent, V., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.87489 · Cited by 458 · see citing works
Amato, E., Molin, M. D., Mafficini, A., Yu, J. Q., Malleo, G., Rusev, B. C., Fassan, M., Antonello, D., Sadakari, Y., Castelli, P., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4344 · Cited by 349 · see citing works
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
Pattabiraman, D. R., Bierie, B., Kober, K. I., Thiru, P., Krall, J. A., Zill, C., Reinhardt, F., Tam, W. L., & Weinberg, R. A. (2016) · Science · doi:10.1126/science.aad3680 · Cited by 332 · see citing works
The metabolic fate of acetate in cancer
Schug, Z. T., Vande Voorde, J., & Gottlieb, E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.87 · Cited by 331 · see citing works
Gerhart‐Hines, Z., Dominy, J. E., Blättler, S. M., Jedrychowski, M. P., Banks, A. S., Lim, J.-H., Chim, H., Gygi, S. P., & Puigserver, P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.12.005 · Cited by 323 · see citing works
Padanad, M. S., Konstantinidou, G., Venkateswaran, N., Melegari, M., Rindhe, S., Mitsche, M. A., Yang, C., Batten, K. G., Huffman, K. E., Liu, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.009 · Cited by 304 · see citing works
Bricambert, J., Miranda, J., Benhamed, F., Girard, J. R., Postic, C., & Dentin, R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41624 · Cited by 299 · see citing works
Mino-Kenudson, M. A., Castillo, C. F.-D., Baba, Y., Valsangkar, N. P., Liss, A. S., Hsu, M., Correa‐Gallego, C., Ingkakul, T., Johnston, R. P., Turner, B. G., et al. (2011) · Gut · doi:10.1136/gut.2010.232272 · Cited by 292 · see citing works
Self-citationClark, K., MacKenzie, K. F., Petkevicius, K., Kristariyanto, Y. A., Zhang, J., Choi, H. G., Peggie, M. W., Plater, L., Pedrioli, P. G. A., McIver, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215450109 · Cited by 252 · see citing works
A Hormone-Dependent Module Regulating Energy Balance
Wang, B., Moya, N., Niessen, S., Hoover, H. S., Mihaylova, M. M., Shaw, R. J., Yates, J. R., Fischer, W. H., Thomas, J. B., & Montminy, M. (2011) · Cell · doi:10.1016/j.cell.2011.04.013 · Cited by 242 · see citing works
Benjamin, D. I., Cozzo, A. J., Ji, X., Roberts, L. S., Louie, S. M., Mulvihill, M. M., Luo, K., & Nomura, D. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310894110 · Cited by 237 · see citing works
Self-citationPancreatic Cystic Neoplasms: Management and Unanswered Questions
Farrell, J. J., & Castillo, C. F. F.-D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.073 · Cited by 223 · see citing works
Self-citationLim, J.-H., Gerhart-Hines, Z., Dominy, J. E., Lee, Y., Kim, S., Tabata, M., Xiang, Y. K., & Puigserver, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.415729 · Cited by 212 · see citing works
von Figura, G., Fukuda, A., Roy, N., Liku, M. E., Morris IV, J. P., Kim, G. E., Russ, H. A., Firpo, M. A., Mulvihill, S. J., Dawson, D. W., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2916 · Cited by 190 · see citing works
Miranda, F., Mannion, D., Liu, S., Zheng, Y., Mangala, L. S., Redondo, C., Herrero‐González, S., Xu, R., Taylor, C., Fotso, D. C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.020 · Cited by 167 · see citing works
The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver
Patel, K. A., Foretz, M., Marion, A., Campbell, D. G., Gourlay, R., Boudaba, N., Tournier, E., Titchenell, P. M., Peggie, M. W., Deák, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5535 · Cited by 162 · see citing works
Self-citationLapek, J. D., Greninger, P., Morris, R. T., Amzallag, A., Pruteanu-Malinici, I., Benes, C. H., & Haas, W. (2017) · Nature Biotechnology · doi:10.1038/nbt.3955 · Cited by 159 · see citing works
Self-citationSIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis
Cheng, H.-L. M., Liu, P., Wang, Z. C., Zou, L., Santiago, S., Garbitt, V. M., Gjoerup, O. V., Iglehart, J. D., Miron, A., Richardson, A. L., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000369 · Cited by 158 · see citing works
Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes
Prentki, M., & Madiraju, S. R. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.004 · Cited by 155 · see citing works
Measurement of Fatty Acid Oxidation Rates in Animal Tissues and Cell Lines
Huynh, F. K., Green, M. F., Koves, T. R., & Hirschey, M. D. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00020-0 · Cited by 154 · see citing works
Louie, S. M., Roberts, L. S., Mulvihill, M. M., Luo, K., & Nomura, D. K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.008 · Cited by 154 · see citing works
Self-citationIglesias‐Bartolomé, R., Torres, D., Marone, R., Feng, X., Martı́n, D., Simaan, M., Chen, M., Weinstein, L. S., Taylor, S. S., Molinolo, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3164 · Cited by 147 · see citing works
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity
Louie, S. M., Grossman, E. A., Crawford, L. A., Ding, L., Camarda, R., Huffman, T. R., Miyamoto, D. K., Goga, A., Weerapana, E., & Nomura, D. K. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.03.017 · Cited by 145 · see citing works
Self-citationIntegrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes
Domínguez, E., Galmozzi, A., Chang, J. W., Hsu, K., Pawlak, J., Li, W., Godio, C., Thomas, J. R., Partida, D., Niessen, S., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1429 · Cited by 136 · see citing works
Self-citationPKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development
Drelon, C., Berthon, A., Sahut-Barnola, I., Mathieu, M., Dumontet, T., Rodriguez, S., Batisse-Lignier, M., Tabbal, H., Tauveron, I., Lefrançois-Martinez, A.-M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12751 · Cited by 128 · see citing works
Patra, K. C., Bardeesy, N. M., & Mizukami, Y. (2017) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2017.3 · Cited by 126 · see citing works
Self-citationThe G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog−driven medulloblastoma
He, X., Zhang, L., Chen, Y., Remke, M., Shih, D. J. H., Lu, F., Wang, H., Deng, Y., Yu, Y., Xia, Y., et al. (2014) · Nature Medicine · doi:10.1038/nm.3666 · Cited by 121 · see citing works
Xing, F., Luan, Y., Cai, J., Wu, S., Mai, J., Gu, J., Zhang, H., Li, K., Lin, Y., Xiao, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.037 · Cited by 120 · see citing works
Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila
Wehr, M. C., Holder, M. V., Gailite, I., Saunders, R. E., Maile, T. M., Ciirdaeva, E., Instrell, R., Jiang, M., Howell, M. T., Rossner, M. J., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2658 · Cited by 108 · see citing works
Hepatobiliary and Pancreatic Neoplasms in Patients With McCune-Albright Syndrome
Gaujoux, S., Salenave, S., Ronot, M., Rangheard, A. ‐., Cros, J. F., Belghiti, J., Sauvanet, A., Ruszniewski, P. B., & Chanson, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1823 · Cited by 92 · see citing works
Protein kinase A and its role in human neoplasia: the Carney complex paradigm.
Bossis, I., Voutetakis, A., Bei, T. A., Sandrini, F., Griffin, K., & Stratakis, C. A. (2004) · Endocrine Related Cancer · doi:10.1677/erc.0.0110265 · Cited by 91 · see citing works
Isolation, culture and genetic manipulation of mouse pancreatic ductal cells
Reichert, M., Takano, S., Heeg, S., Bakir, B. S., Botta, G., & Rustgi, A. (2013) · Nature Protocols · doi:10.1038/nprot.2013.079 · Cited by 89 · see citing works
A genetic and molecular update on adrenocortical causes of Cushing syndrome
Lodish, M. B., & Stratakis, C. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.24 · Cited by 88 · see citing works
SIK2 Is Critical in the Regulation of Lipid Homeostasis and Adipogenesis In Vivo
Park, J., Yoon, Y.-S., Han, H.-S., Kim, Y., Ogawa, Y., Park, K., Lee, C., Kim, S., & Koo, S. (2014) · Diabetes · doi:10.2337/db13-1423 · Cited by 74 · see citing works
14‐3‐3 proteins mediate inhibitory effects of cAMP on salt‐inducible kinases ( SIK s)
Sonntag, T., Vaughan, J. M., & Montminy, M. (2017) · FEBS Journal · doi:10.1111/febs.14351 · Cited by 66 · see citing works
Taki, K., Ohmuraya, M., Tanji, E., Komatsu, H., Hashimoto, D., Semba, K., Araki, K., Kawaguchi, Y., Baba, H., & Furukawa, T. (2016) · Oncogene · doi:10.1038/onc.2015.294 · Cited by 64 · see citing works
Cholesterol-Independent SREBP-1 Maturation Is Linked to ARF1 Inactivation
Smulan, L. J., Ding, W., Freinkman, E., Gujja, S., Edwards, Y. J. K., & Walker, A. K. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.086 · Cited by 56 · see citing works
Gαs regulates the post-endocytic sorting of G protein-coupled receptors
Rosciglione, S., Thériault, C., Boily, M.-O., Paquette, M., & Lavoie, C. L. (2014) · Nature Communications · doi:10.1038/ncomms5556 · Cited by 50 · see citing works
Li, Y., Shrestha, Y. B., Chen, M., Chanturiya, T., Gavrilova, O., & Weinstein, L. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517142113 · Cited by 35 · see citing works
Wilderman, A. S., Guo, Y., Divakaruni, A. S., Perkins, G. A., Zhang, L., Murphy, A. N., Taylor, S. S., & Insel, P. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658153 · Cited by 11 · see citing works
GNAS Mutations: Drivers or Co-Pilots? Yet, Promising Diagnostic Biomarkers
Innamorati, G., Valenti, M. T., Giacomello, L., Carbonare, L. D., & Bassi, C. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.05.005 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321 · see citing works
Complex roles of cAMP–PKA–CREB signaling in cancer
Zhang, H., Kong, Q., Wang, J., Jiang, Y., & Hua, H. M. (2020) · Experimental Hematology and Oncology · doi:10.1186/s40164-020-00191-1 · Cited by 472 · see citing works
Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies
Cervantes‐Villagrana, R. D., Albores‐García, D., Cervantes-Villagrana, A. R., & García-Acevez, S. J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0205-z · Cited by 299 · see citing works
Metabolic reprogramming in cancer: Mechanisms and therapeutics
Nong, S., Han, X., Yu, X., Qian, Y., Wei, Y., Zhang, T., Tian, K., Shen, K., Yang, J., & Ma, X. (2023) · MedComm · doi:10.1002/mco2.218 · Cited by 292 · see citing works
Omori, Y., Ono, Y., Tanino, M. A., Karasaki, H., Yamaguchi, H., Furukawa, T., Enomoto, K., Ueda, J., Sumi, A., Katayama, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.029 · Cited by 189 · see citing works
Self-citationWu, V. H., Yeerna, H., Nohata, N., Chiou, J., Harismendy, O., Raimondi, F., Inoue, A., Russell, R. B., Tamayo, P., & Gutkind, J. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.005601 · Cited by 177 · see citing works
Harnessing metabolic dependencies in pancreatic cancers
Encarnación-Rosado, J., & Kimmelman, A. C. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00431-7 · Cited by 180 · see citing works
The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC
Hollstein, P. E., Eichner, L. J., Brun, S. N., Kamireddy, A., Svensson, R. U., Vera, L. I., Ross, D. S., Rymoff, T. J., Hutchins, A., Galvez, H. M., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1261 · Cited by 168 · see citing works
Self-citationSinghi, A. D., Wood, L. D., Parks, E., Torbenson, M. S., Felsenstein, M., Hruban, R. H., Nikiforova, M. N., Wald, A. I., Kaya, C., Nikiforov, Y. E., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.10.028 · Cited by 167 · see citing works
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
Weiss‐Sadan, T., Ge, M., Hayashi, M., Gohar, M., Yao, C.-H., de Groot, A., Harry, S. A., Carlin, A. D., Fischer, H., Shi, L., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.012 · Cited by 156 · see citing works
Self-citationcAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Zhang, H., Liu, Y., Liu, J., Chen, J., Wang, J., Hua, H. M., & Jiang, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01524-x · Cited by 149 · see citing works
KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
Pupo, E., Avanzato, D., Middonti, E., Bussolino, F., & Lanzetti, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00848 · Cited by 144 · see citing works
The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis
Sun, Z., Jiang, Q., Li, J., & Guo, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00265-w · Cited by 130 · see citing works
Nuts and bolts of the salt-inducible kinases (SIKs)
Darling, N. J., & Cohen, P. (2021) · Biochemical Journal · doi:10.1042/bcj20200502 · Cited by 134 · see citing works
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
Yin, X., Xu, R., Song, J., Ruze, R., Chen, Y., Wang, C., & Xu, Q. (2022) · 癌症：英文版 · doi:10.1002/cac2.12360 · Cited by 132 · see citing works
Yang, Y., Gabra, M. B. I., Hanse, E. A., Lowman, X. H., Tran, T. Q., Li, H., Milman, N., Liu, J., Reid, M. A., Locasale, J. W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08759-0 · Cited by 129 · see citing works
Huang, L., Desai, R., Conrad, D. N., Leite, N. C., Akshinthala, D., Lim, C. M., González, R. S., Muthuswamy, L. B., Gartner, Z. J., & Muthuswamy, S. K. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.03.022 · Cited by 119 · see citing works
Non-canonical β-adrenergic activation of ERK at endosomes
Kwon, Y., Mehta, S., Clark, M. J., Walters, G., Zhong, Y., Lee, H. N., Sunahara, R. K., & Zhang, J. (2022) · Nature · doi:10.1038/s41586-022-05343-3 · Cited by 116 · see citing works
An LKB1–SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation
Murray, C. W., Brady, J. J., Tsai, M. K., Li, C., Winters, I. P., Tang, R., Andrejka, L., Ma, R. K., Kunder, C. A., Chu, P., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1237 · Cited by 111 · see citing works
Breunig, M., Merkle, J., Wagner, M., Melzer, M. K., Barth, T. F. E., Engleitner, T., Krumm, J., Wiedenmann, S., Cohrs, C. M., Perkhofer, L., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.03.005 · Cited by 110 · see citing works
Ruze, R., Song, J., Yin, X., Chen, Y., Xu, R., Wang, C., & Zhao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01376-w · Cited by 103 · see citing works
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Wu, H., Fu, M., Wu, M., Cao, Z., Zhang, Q., & Liu, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06930-0 · Cited by 87 · see citing works
Ramms, D. J., Raimondi, F., Arang, N., Herberg, F. W., Taylor, S. S., & Gutkind, J. S. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000269 · Cited by 71 · see citing works
Mitochondria-centric bioenergetic characteristics in cancer stem-like cells
Shin, M., & Cheong, J. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01127-y · Cited by 72 · see citing works
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
Kung, H., Zheng, K., Zimmerman, J. W., & Zheng, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01077-z · Cited by 69 · see citing works
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Liu, Y.-H., Hu, C., Hsu, Y.-S., & Lee, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05259-w · Cited by 66 · see citing works
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zhang, Z., Zhang, H., Liao, X., & Tsai, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147676 · Cited by 62 · see citing works
Uncertain Beginnings: Acinar and Ductal Cell Plasticity in the Development of Pancreatic Cancer
Grimont, A., Leach, S. D., & Chandwani, R. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.014 · Cited by 58 · see citing works
Bazzichetto, C., Luchini, C., Conciatori, F., Vaccaro, V., Cello, I. D., Mattiolo, P., Falcone, I., Ferretti, G., Scarpa, A., Cognetti, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228841 · Cited by 56 · see citing works
Salt-Inducible Kinase 2: An Oncogenic Signal Transmitter and Potential Target for Cancer Therapy
Chen, F., Chen, L., Qin, Q., & Sun, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00018 · Cited by 53 · see citing works
REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumorsPreprint
Qiao, S., Koh, S., Vivekanandan, V., Salunke, D., Patra, K. C., Zaganjor, E., Ross, K. N., Mizukami, Y., Jeanfavre, S., Chen, A. L., et al. (2020) · Genes & Development · doi:10.1101/gad.335166.119 · Cited by 52 · see citing works
Self-citationXue, C., He, Y., Zhu, W., Chen, X., Yu, Y. H., Hu, Q., Chen, J., Liu, L., Ren, F., Ren, Z., et al. (2018) · Europe PMC (PubMed Central) · Cited by 50 · see citing works
Booth, L. A., Roberts, J. L., Sander, C., Lalani, A. S., Kirkwood, J. M., Hancock, J. F., Poklepovic, A. S., & Dent, P. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1551747 · Cited by 49 · see citing works
hsa_circRNA_100533 regulates GNAS by sponging hsa_miR_933 to prevent oral squamous cell carcinoma
Zhu, X., Shao, P., Tang, Y., Shu, M., Hu, W., & Zhang, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29245 · Cited by 48 · see citing works
Lippman, S. M., Abate-Shen, C. T., Maresso, K. C., Colditz, G. A., Dannenberg, A. J., Davidson, N. E., Disis, M. L., DuBois, R. N., Szabo, E. M., Giuliano, A. R., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0421 · Cited by 47 · see citing works
Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms
Zhou, B., Wu, D., Liu, H., Du, L., Wang, Y., Xu, J., Qiu, F., Hu, S., & Zhan, H. (2019) · Pancreatology · doi:10.1016/j.pan.2019.08.008 · Cited by 47 · see citing works
Berdeaux, R., & Hutchins, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00535 · Cited by 46 · see citing works
Cui, Y., Miao, Y., Cao, L., Guo, L., Cui, Y., Yan, C., Zeng, Z., Xu, M., & Han, T. (2023) · Nature Communications · doi:10.1038/s41467-023-41101-3 · Cited by 43 · see citing works
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
Rozengurt, E., & Eibl, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02499-y · Cited by 47 · see citing works
Mas, L., Lupinacci, R. M., Cros, J. F., Bachet, J., Coulet, F., & Svrcek, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136756 · Cited by 43 · see citing works
Sen, U., Coleman, C. J., Gandhi, N. S., Jethalia, V., Demircioğlu, D., Elliott, A., Vanderwalde, A. M., Hayatt, O., de Stanchina, E., Halmos, B., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2745 · Cited by 41 · see citing works
Gaiser, R. A., Pessia, A., Ateeb, Z., Davanian, H., Moro, C. F., Alkharaan, H., Healy, K., Ghazi, S. H., Arnelo, U., Valente, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46634-6 · Cited by 39 · see citing works
Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
Saiki, Y., Jiang, C., Ohmuraya, M., & Furukawa, T. (2021) · Cancers · doi:10.3390/cancers14010071 · Cited by 38 · see citing works
PRKDC Induces Chemoresistance in Osteosarcoma by Recruiting GDE2 to Stabilize GNAS and Activate AKT
Zhang, W., Li, W., Yin, C., Feng, C., Liu, B., Xu, H., Jin, X., Tu, C., & Li, Z. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0163 · Cited by 39 · see citing works
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer
Xia, W., Bai, H., Deng, Y., & Yang, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15832 · Cited by 36 · see citing works
The landscape of cancer-rewired GPCR signaling axes
Arora, C., Matic, M., Bisceglia, L., Chiaro, P. D., Rosa, N. D. O., Carli, F., Clubb, L. M., Fard, L. A. N., Kargas, G., Diaferia, G. R., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100557 · Cited by 36 · see citing works
Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
Chen, K., Wu, S., Ye, S., Huang, H., Zhou, Y., Zhou, H., Wu, S., Mao, Y., Shangguan, F., Lan, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.617714 · Cited by 34 · see citing works
Humoral Predictors of Malignancy in IPMN: A Review of the Literature
Nista, E. C., Schepis, T., Candelli, M., Giuli, L., Pignataro, G., Franceschi, F., Gasbarrini, A., & Ojetti, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312839 · Cited by 34 · see citing works
Ohtsuka, T., Tomosugi, T., Kimura, R., Nakamura, S., Miyasaka, Y., Nakata, K., Mori, Y., Morita, M., Torata, N., Shindo, K., et al. (2019) · Surgery Today · doi:10.1007/s00595-019-01797-7 · Cited by 34 · see citing works
Dai, X., Zhang, Y., Lin, X., Huang, X., Zhang, Y., Xue, C., Chen, W., Ye, J., Lin, X., & Lin, X. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12838 · Cited by 33 · see citing works
Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms
Chan, G. K. L., Maisel, S., Hwang, Y. C., Pascual, B. C., Wolber, R. R., Vu, P., Patra, K. C., Bouhaddou, M., Kenerson, H. L., Lim, H. C., et al. (2023) · eLife · doi:10.7554/elife.69521 · Cited by 32 · see citing works
Self-citationRaimondi, F., Inoue, A., Kadji, F. M. N., Ni, S., González‐Sánchez, J. C., Singh, G., de la Vega, A. A., Sotillo, R., Fischer, B., Aoki, J., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0895-2 · Cited by 30 · see citing works
Adaptive Transcriptional Responses by CRTC Coactivators in Cancer
Tasoulas, J., Rodón, L., Kaye, F. J., Montminy, M., & Amelio, A. L. (2019) · Trends in cancer · doi:10.1016/j.trecan.2018.12.002 · Cited by 29 · see citing works
Omori, Y., Ono, Y., Kobayashi, T., Motoi, F., Karasaki, H., Mizukami, Y., Makino, N., Ueno, Y., Unno, M., & Furukawa, T. (2020) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-020-02806-8 · Cited by 29 · see citing works
Self-citationUpdate on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment
Larribère, L., & Utikal, J. S. (2020) · Cancers · doi:10.3390/cancers12061524 · Cited by 29 · see citing works
Kawabata, H., Ono, Y., Tamamura, N., Oyama, K., Ueda, J., Sato, H., Takahashi, K., Taniue, K., Okada, T., Fujibayashi, S., et al. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-021-01846-4 · Cited by 28 · see citing works
Self-citationZhou, Y., Jia, K., Wang, S., Li, Z., Li, Y., Lu, S., Yang, Y., Zhang, L., Wang, M., Dong, Y., et al. (2022) · Hepatology · doi:10.1002/hep.32487 · Cited by 28 · see citing works
LKB1 biology: assessing the therapeutic relevancy of LKB1 inhibitors
Trelford, C. B., & Shepherd, T. G. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01689-5 · Cited by 25 · see citing works
Zewdu, R., Mehrabad, E. M., Ingram, K., Fang, P., Gillis, K. L., Camolotto, S. A., Orstad, G., Jones, A. D., Mendoza, M. C., Spike, B. T., et al. (2021) · eLife · doi:10.7554/elife.66788 · Cited by 22 · see citing works
Current status of molecular diagnostic approaches using liquid biopsy
Takahashi, K., Takeda, Y., Ono, Y., Isomoto, H., & Mizukami, Y. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02024-4 · Cited by 25 · see citing works
Self-citationThe landscape of GPCR signaling in the regulation of epidermal stem cell fate and skin homeostasis
Pedro, M. P., Lund, K., & Iglesias‐Bartolomé, R. (2020) · Stem Cells · doi:10.1002/stem.3273 · Cited by 25 · see citing works
Oncogene addiction to GNAS in GNASR201 mutant tumors
More, A., Ito, I., Haridas, V., Chowdhury, S., Gu, Y., Dickson, P. N., Fowlkes, N. W., & Shen, J. P. (2022) · Oncogene · doi:10.1038/s41388-022-02388-6 · Cited by 25 · see citing works
Bandi, D. S. R., Sarvesh, S., Farran, B., Nagaraju, G. P., & El‐Rayes, B. F. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.06.006 · Cited by 25 · see citing works
Metabolic plasticity in pancreatic cancer: The mitochondrial connection
Noemi, G., Abbo, D., Anastasia, B., Costamagna, A., Porporato, P. E., & Martini, M. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102089 · Cited by 24 · see citing works
SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis
Zhang, H., Ma, T., Wen, X., Jiang, J., Chen, J., Jiang, J., Xie, J., Mo, T., Li, R., Xie, H., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217726 · Cited by 24 · see citing works
Ognjenovic, N. B., Bagheri, M., Mohamed, G. A., Xu, K., Chen, Y., Saleem, M.-A. M., Brown, M. S., Nagaraj, S. H., Muller, K. E., Gerber, S. A., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.10.004 · Cited by 24 · see citing works
Kwee, S. A., & Tiirikainen, M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.124 · Cited by 24 · see citing works
Raab, M., Rak, M., Tesch, R., Gasimli, K., Becker, S., Knapp, S., Strebhardt, K., & Sanhaji, M. (2021) · Cancers · doi:10.3390/cancers13153658 · Cited by 22 · see citing works
AMPK-Mediated Lysosome Biogenesis in Lung Cancer Growth
Patra, K. C., Weeresekara, V., & Bardeesy, N. M. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.011 · Cited by 22 · see citing works
Self-citationGritti, I., Wan, J., Weeresekara, V., Vaz, J. M., Tarantino, G., Bryde, T. H., Vijay, V., Kammula, A. V., Kattel, P., Zhu, S., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0634 · Cited by 20 · see citing works
Self-citationGiudice, S. D., Luca, V. D., Parizadeh, S., Russo, D., Luini, A., & Martino, R. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.833663 · Cited by 19 · see citing works
Mechanisms of development and progression of pancreatic neoplasms
Furukawa, T. (2022) · Pathology International · doi:10.1111/pin.13272 · Cited by 20 · see citing works
Shockley, K., To, B., Chen, W., Lozanski, G., Cruz‐Monserrate, Z., & Krishna, S. G. (2023) · Cancers · doi:10.3390/cancers15061722 · Cited by 20 · see citing works
Cervantes‐Villagrana, R. D., García‐Jiménez, I., & Vázquez‐Prado, J. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110749 · Cited by 20 · see citing works
Li, Y., Li, C., Liu, Y., Yu, J., Yang, J., Cui, Y., Wang, T. V., Li, C., Jiang, L., Song, M., et al. (2023) · Genetics · doi:10.1093/genetics/iyad136 · Cited by 20 · see citing works
Magrath, J. W., Espinosa-Cotton, M. M., Flinchum, D. A., Sampath, S. S., Cheung, N. V., & Lee, S. B. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1442488 · Cited by 21 · see citing works
Visser, I. J., Levink, I. J. M., Peppelenbosch, M. P., Fuhler, G. M., Bruno, M. J., & Cahen, D. L. (2022) · Pancreatology · doi:10.1016/j.pan.2022.06.260 · Cited by 20 · see citing works
Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors
Johannet, P. M., Abdelfattah, S., Wilde, C. M., Patel, S. D., Walch, H. S., Rousseau, B., Argilés, G., Artz, O., Patel, M., Arfè, A., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.24.00186 · Cited by 19 · see citing works
Whole-exome sequencing reveals the etiology of the rare primary hepatic mucoepidermoid carcinoma
Hou, P., Su, X., Cao, W., Xu, L., Zhang, R., Huang, Z., Wang, J., Li, L., Wu, L., & Liao, W. (2021) · Diagnostic Pathology · doi:10.1186/s13000-021-01086-3 · Cited by 19 · see citing works
Protein kinase A and local signaling in cancer
Rosenthal, K. J., Gordan, J. D., & Scott, J. D. (2024) · Biochemical Journal · doi:10.1042/bcj20230352 · Cited by 18 · see citing works
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
du Toit‐Thompson, T., Leck, L. Y. W., Gillson, J., Pavlakis, N., Gill, A. J., Samra, J. S., Mittal, A., & Sahni, S. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115647 · Cited by 20 · see citing works
The biology of pancreatic cancer morphology
McDonald, O. G. (2021) · Pathology · doi:10.1016/j.pathol.2021.09.012 · Cited by 18 · see citing works
A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation
Drozdz, M. M., Doane, A. S., Alkallas, R., Desman, G. T., Bareja, R., Reilly, M., Bang, J., Yusupova, M., You, J., Eraslan, Z., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111412 · Cited by 18 · see citing works
Evrard, C., Ingrand, P., Rochelle, T., Martel, M., Tachon, G., Flores, N., Randrian, V., Ferru, A., Haineaux, P.-A., Goujon, J., et al. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.03.011 · Cited by 18 · see citing works
Lipid Metabolism in Cancer Cells
Zheng, M., Wang, W., Liu, J., Zhang, X., & Zhang, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_4 · Cited by 18 · see citing works
Chen, H., Yang, Z., Sun, Y., Yin, S., Tang, M., & Zhang, F. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2703095 · Cited by 15 · see citing works
Current Pathology Model of Pancreatic Cancer
Szymoński, K., Milian-Ciesielska, K., Lipiec, E. W., & Adamek, D. (2022) · Cancers · doi:10.3390/cancers14092321 · Cited by 15 · see citing works
Yagi, H., Onoyama, I., Asanoma, K., Hori, E., Yasunaga, M., Kodama, K., Kijima, M., Ohgami, T., Kaneki, E., Okugawa, K., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901278r · Cited by 16 · see citing works
Morphologic and Molecular Findings in Myxoid Hepatic Adenomas
Rowan, D. J., Yasir, S., Chen, Z. E., Mounajjed, T., Damgard, S. E., Cummins, L., Zhang, L., Whitcomb, E., Falck, V., Simon, S. M., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001711 · Cited by 16 · see citing works
Sato, H., Liss, A. S., & Mizukami, Y. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i23.3262 · Cited by 16 · see citing works
Self-citationGene Therapy for Pancreatic Diseases: Current Status
Kamimura, K., Yokoo, T., & Terai, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113415 · Cited by 16 · see citing works
Shi, R., Li, X., Zhang, J., Chen, F., Ma, M., Feng, Y., & Li, T. (2022) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1861 · Cited by 15 · see citing works
Models of pancreatic ductal adenocarcinoma
Dennaoui, R., Shrestha, H., & Wagner, K.-U. (2021) · Cancer Metastasis Review · doi:10.1007/s10555-021-09989-9 · Cited by 13 · see citing works
Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects
Zhang, J., Kong, X., Zhou, B., Li, R., Yu, Z., Zhu, J., Xi, Q., Li, Y., Zhao, Z., & Zhang, R. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101368 · Cited by 14 · see citing works
Shields, M. A., Spaulding, C., Metropulos, A. E., Khalafalla, M. G., Pham, T. D., & Munshi, H. G. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110441 · Cited by 14 · see citing works
Molecular Pathology of Pancreatic Cystic Lesions with a Focus on Malignant Progression
Hu, Y., Jones, D. M., Esnakula, A. K., Krishna, S. G., & Chen, W. (2024) · Cancers · doi:10.3390/cancers16061183 · Cited by 14 · see citing works
An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis
Yan, H., Zhang, J.-L., Leung, K. T., Lo, K. W., Yu, J. Q., To, K., & Kang, W. (2023) · Cancers · doi:10.3390/cancers15030736 · Cited by 13 · see citing works
Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer
Guo, D., Ye, L., Wu, W., Yu, X., & Jin, K. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023045 · Cited by 13 · see citing works
Xu, Y., Xue, D., Kyani, A., Bankhead, A., Roy, J., Ljungman, M. E., & Neamati, N. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00069 · Cited by 13 · see citing works
Du, L., Wilson, B. A. P., Li, N., Shah, R., Dalilian, M., Wang, D., Smith, E. A., Wamiru, A., Goncharova, E. I., Zhang, P., et al. (2023) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00394 · Cited by 13 · see citing works
- Authors
- Patra, K. C., Kato, Y., Mizukami, Y., Widholz, S., Boukhali, M., Revenco, I., Grossman, E. A., Ji, F., Sadreyev, R. I., Liss, A. S., Screaton, R. A., Sakamoto, K., Ryan, D. P., Mino-Kenudson, M., Castillo, C. F.-D., Nomura, D. K., Haas, W., & Bardeesy, N.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Asahikawa Medical University (JP)
- University of California, Berkeley (US)
- University of Toronto (CA)
- University of Dundee (GB)
- Corresponding author
- Bardeesy, Nabeel
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2018-06-25
- Volume
- 20
- Issue
- 7
- Pages
- 811-822
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC6044476
- OpenAlex
- W2809279418
- Cited by
- 192
- References
- 70
- Citations by year
- 2026: 10 · 2025: 35 · 2024: 31 · 2023: 29 · 2022: 21 · 2021: 28 · 2020: 14 · 2019: 19 · 2018: 5
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Japan Society for the Promotion of Science (17K09472)
- National Cancer Institute (P50CA127003, R01CA133557, P01CA117969)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK040561)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- GNAS, pancreatic ductal adenocarcinoma, intraductal papillary mucinous neoplasm, KRAS G12D, cAMP signaling, protein kinase A, salt-inducible kinases, lipid remodeling, fatty acid oxidation, cancer metabolism, p53 deficiency, tumour suppressor, oncogenic mechanisms
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Chromogranins, Enzyme Repression, Fatty Acids, Female, Humans, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Mice, Transgenic, Mutation, Oxidation-Reduction, Pancreatic Neoplasms, Phenotype, Genes, ras, Time Factors, Tumor Cells, Cultured, Signal Transduction, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Mice, Inbred NOD, Protein Serine-Threonine Kinases, Cyclic AMP-Dependent Protein Kinases, GTP-Binding Protein alpha Subunits, Gs, Genetic Predisposition to Disease, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Lipid Metabolism, Mice, 129 Strain, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
